Abstract:Abstract Background and Aims Subclinical sequelae of acute kidney injury (AKI) are commonly associated with the development of chronic kidney disease (CKD). Despite extensive investigation on AKI to CKD transition on different experimental models, the underlying mechanisms of this transition remain unclear, and there are no known biomarkers monitoring this transition to CKD. The liver-type fatty acid-binding protein (L-FABP) is expressed in the kidney under normal and pathological conditions, and seems to play an important role on kidney injury and repair. We evaluated the efficacy of urinary L-FABP excretion as a prognostic indicator of the progression of renal damage in our AKI to CKD experimental model. Method 8 week old male Wistar rats were divided in two experimental groups: “Control” group (n = 8): SHAM-operated rats, which received saline solution i.p; and Cpt-IR2 group (n = 8): 5 mg/kg cisplatin i.p and 2 weeks after renal function normalization, 60 min ischemia-reperfusion on the left kidney. Blood and urine samples were collected at day 0 (basal), day 4 (AKI development), day 8 (normalized renal function), day 24 (1 day after ischemia), and 2 (M2) and 3 (M3) months after first AKI induction. Renal function was estimated analysing by colorimetric methods plasma and urinary creatinine concentrations (pCr and uCr) and creatinine clearance. Animals were sacrificed at days 56 and 90. Tissue samples were stained with haematoxylin-Eeosin, periodic acid Schiff and Masson's Trichrome for histological analysis. Enzyme-linked immunosorbent assay was used to measure urinary L-FABP concentration. Results Cpt-IR2 rats showed a reduction in renal filtration with respect to control rats even though this decrease does not indicate a severe decline in renal function. This group also presented multiple histological alterations such as fibrosis, loss of brush border membrane, inflammatory infiltrates, basement membrane thickening, tubular dilatation, cellular debris and hyaline casts that worsen markedly from M2 to M3. uL-FABP was greater in Cpt-IR2 rats (52,299 ± 8,407 ng/g uCr M2 and 23,427 ± 4,778 ng/g uCr M3) than in control rats (16,657 ± 2,322 ng/g uCr M2 and 10,636 ± 1,395 ng/g uCr), but this urinary excretion does not correlate with the histological alterations in the last month of the study. Conclusion Urinary L-FABP may be a potential biomarker for the detection of the presence of histological damage although it is not correlated with the extent and degree of the damage in our AKI to CKD transition model. This research was funded by grants from Instituto de Salud Carlos III (ISCIII) PI21/00548 and PI21/01226 co-funded by the European Union and Red de Investigación Renal RICORS2040 (Kidney Disease), RD21/0005/0004 co-funded by the European Union – NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR). Joana Mercado-Hernández is recipient of a predoctoral fellowship from the Junta de Castilla y Leon (Spain) and the European Social Fund from the European Commission.

Modified furosemide responsiveness index and biomarkers for AKI progression and prognosis: a prospective observational study

Furosemide responsiveness predicts acute kidney injury progression after cardiac surgery

Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis

Biomarkers for Early Diagnosis of Acute Kidney Injury: Current Progress and Clinical prospects.

MO681: Association of Framingham Risk Score with Mortality in Kidney Failure Patients from China and Sweden

Advances in the study of subclinical AKI biomarkers

The value of urinary kidney injury molecule-1 and urinary liver fatty acid-binding protein as prognostic biomarkers for patients with obstructive nephropathy

Association Between Furosemide Administration and Outcomes in Critically Ill Patients with Acute Kidney Injury.

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients

Urinary Biomarkers At The Time Of Aki Diagnosis As Predictors Of Progression Of Aki Among Patients With Acute Cardiorenal Syndrome

Furosemide stress test to predict acute kidney injury progression in critically ill children

Association Between The Levels Of Urine Kidney Injury Molecule-1 And The Progression Of Acute Kidney Injury In The Elderly

Acute kidney injury biomarker olfactomedin 4 predicts furosemide responsiveness

Predictive value of renal resistive index combined with plasma biomarkers of endothelial cell activation for persistent acute kidney injury in patients with septic shock

An integrated machine learning predictive scheme for longitudinal laboratory data to evaluate the factors determining renal function changes in patients with different chronic kidney disease stages

Novel metabolites to improve glomerular filtration rate estimation

Predictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7

Analysis Of A Urinary Biomarker Panel For Obstructive Nephropathy And Clinical Outcomes

#3937 URINARY EXCRETION OF LIVER-TYPE FATTY ACID-BINDING PROTEIN DETECTS KIDNEY HISTOLOGICAL ALTERATIONS DURING PROGRESSIVE RENAL FIBROSIS

Novel risk models to predict acute kidney disease and its outcomes in a Chinese hospitalized population with acute kidney injury

Evaluating renal microcirculation in patients with acute kidney injury by contrast-enhanced ultrasonography: a protocol for an observational cohort study